Entera Bio Ltd expected to post a loss of 8 cents a share - Earnings Preview

Entera Bio

04/03/2025 11:01

Entera Bio Ltd ENTX.OQ, ENTX.O is expected to show a rise in quarterly revenue when it reports  results on March 6 (estimated) for the period ending December 31 2024

The Jerusalem Israel-based   company is expected to report revenue of $40 thousand, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Entera Bio Ltd is for a loss of 8 cents per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Entera Bio Ltd is $10.00​, above​ its last closing price of $1.93. ​​​

This summary was machine generated March 4 at 11:01 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)